Surgery Partners, Inc. (SGRY): Price and Financial Metrics
SGRY Price/Volume Stats
Current price | $29.94 | 52-week high | $45.79 |
Prev. close | $29.19 | 52-week low | $22.05 |
Day low | $29.11 | Volume | 785,400 |
Day high | $30.16 | Avg. volume | 933,093 |
50-day MA | $31.16 | Dividend yield | N/A |
200-day MA | $32.80 | Market Cap | 3.79B |
SGRY Stock Price Chart Interactive Chart >
SGRY POWR Grades
- Growth is the dimension where SGRY ranks best; there it ranks ahead of 96.35% of US stocks.
- The strongest trend for SGRY is in Stability, which has been heading down over the past 26 weeks.
- SGRY's current lowest rank is in the Value metric (where it is better than 19.7% of US stocks).
SGRY Stock Summary
- SGRY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 478.89 -- higher than 93.03% of US-listed equities with positive expected earnings growth.
- Of note is the ratio of SURGERY PARTNERS INC's sales and general administrative expense to its total operating expenses; only 19.69% of US stocks have a lower such ratio.
- For SGRY, its debt to operating expenses ratio is greater than that reported by 91.16% of US equities we're observing.
- Stocks that are quantitatively similar to SGRY, based on their financial statements, market capitalization, and price volatility, are COLD, CBL, GSAT, MTZ, and KW.
- SGRY's SEC filings can be seen here. And to visit SURGERY PARTNERS INC's official web site, go to www.surgerypartners.com.
SGRY Valuation Summary
- SGRY's price/sales ratio is 1.5; this is 64.29% lower than that of the median Healthcare stock.
- SGRY's price/sales ratio has moved down 0.7 over the prior 100 months.
Below are key valuation metrics over time for SGRY.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SGRY | 2023-12-29 | 1.5 | 2.0 | -118.0 | 38.7 |
SGRY | 2023-12-28 | 1.5 | 2.0 | -118.6 | 38.8 |
SGRY | 2023-12-27 | 1.5 | 2.0 | -119.2 | 38.9 |
SGRY | 2023-12-26 | 1.5 | 2.0 | -119.2 | 38.9 |
SGRY | 2023-12-22 | 1.5 | 2.0 | -118.9 | 38.9 |
SGRY | 2023-12-21 | 1.5 | 2.1 | -122.0 | 39.5 |
SGRY Growth Metrics
- Its year over year cash and equivalents growth rate is now at -30.08%.
- The 3 year revenue growth rate now stands at 30.38%.
- Its year over year net income to common stockholders growth rate is now at 74.85%.
The table below shows SGRY's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 2,539.3 | 158.8 | -54.6 |
2022-09-30 | 2,442.4 | 171.3 | -31.3 |
2022-06-30 | 2,381 | 156.5 | -29.2 |
2022-03-31 | 2,308.9 | 116.7 | -37.7 |
2021-12-31 | 2,225.1 | 87.1 | -81.2 |
2021-09-30 | 2,163.2 | 76.3 | -85.9 |
SGRY's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SGRY has a Quality Grade of D, ranking ahead of 15.29% of graded US stocks.
- SGRY's asset turnover comes in at 0.388 -- ranking 64th of 81 Healthcare stocks.
- LHCG, RHE, and ENSG are the stocks whose asset turnover ratios are most correlated with SGRY.
The table below shows SGRY's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.388 | 0.222 | 0.034 |
2021-06-30 | 0.382 | 0.224 | 0.024 |
2021-03-31 | 0.358 | 0.211 | 0.023 |
2020-12-31 | 0.353 | 0.204 | 0.016 |
2020-09-30 | 0.354 | 0.204 | 0.011 |
2020-06-30 | 0.352 | 0.201 | 0.022 |
SGRY Price Target
For more insight on analysts targets of SGRY, see our SGRY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $65.83 | Average Broker Recommendation | 1.38 (Strong Buy) |
Surgery Partners, Inc. (SGRY) Company Bio
Surgery Partners Inc. is a healthcare services company focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of the company's patients and physicians. The company was founded in 2004 and is based in Nashville, Tennessee.
Latest SGRY News From Around the Web
Below are the latest news stories about SURGERY PARTNERS INC that investors may wish to consider to help them evaluate SGRY as an investment opportunity.
Insider Sell: Exec Chairman Wayne Deveydt Sells 168,130 Shares of Surgery Partners Inc (SGRY)Wayne Deveydt, the Executive Chairman of the Board of Surgery Partners Inc (NASDAQ:SGRY), has executed a significant stock sale according to a recent SEC filing. |
Surgery Partners, Inc. Announces Proposed Secondary Offering of Common StockBRENTWOOD, Tenn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners” or the “Company”) today announced that certain of the Company’s stockholders (the “Selling Stockholders”) intend to offer for sale in an underwritten secondary offering (the “Offering”) 8,000,000 shares of the Company’s common stock, par value $0.01 per share. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be c |
Here’s Why Surgery Partners (SGRY) Declined in Q3ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Rising bond rates and the Federal Reserve’s shift to a more hawkish stance put pressure on stocks in the third quarter. The strategy underperformed its Russell 3000 Index in the third […] |
Does Insulet (PODD) Face Challenges from the New Weight Loss Drug?ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Rising bond rates and the Federal Reserve’s shift to a more hawkish stance put pressure on stocks in the third quarter. The strategy underperformed its Russell 3000 Index in the third […] |
Surgery Partners, Inc. Completes Refinancing TransactionBRENTWOOD, Tenn., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company, has received commitments for a new $1.4 billion senior secured term loan (the “New Term Loan”). Upon closing (such date, the “Closing Date”), the new Term Loan will bear interest at a rate equal to 3.50% per annum in ex |
SGRY Price Returns
1-mo | -5.97% |
3-mo | -6.41% |
6-mo | 2.36% |
1-year | -8.44% |
3-year | -29.72% |
5-year | 165.43% |
YTD | -6.41% |
2023 | 14.82% |
2022 | -47.84% |
2021 | 84.11% |
2020 | 85.31% |
2019 | 59.91% |
Continue Researching SGRY
Want to see what other sources are saying about Surgery Partners Inc's financials and stock price? Try the links below:Surgery Partners Inc (SGRY) Stock Price | Nasdaq
Surgery Partners Inc (SGRY) Stock Quote, History and News - Yahoo Finance
Surgery Partners Inc (SGRY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...